Caryn Parlavecchio Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 5 days ago
Caryn Parlavecchio has an estimated net worth of at least $10.1 million*, as of April 8, 2026. They own 169,087 shares of SRRK stock. They have sold 49,438 shares of SRRK stock since 2021, for an estimated $1.6 million.
Caryn Parlavecchio $SRRK SEC Form 4 Insider Trading
Caryn Parlavecchio has filed a total of 11 insider trades in $SRRK since 2021. Their most recent trade was a sale of 9,035 shares, made on Feb 17, 2026. Their largest trade was a sale of 9,035 shares, made on Feb 17, 2026. We estimate that they now own 169,087 shares of $SRRK, worth an estimated $8.5 million.
Insider Trading at $SRRK
There have been a total of 150 insider trades reported at $SRRK since 2021, with 8.6 million shares purchased and 4.7 million shares sold. The most active insider traders in $SRRK stock have been Mo Qatanani, Edward H Myles, and Jing L. Marantz. The most recent trade was a sale of 10,220 shares reported by Keith Woods (Chief Operating Officer), made on Apr 16, 2026.
History of Insider Stock Trades by Caryn Parlavecchio
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
SRRK
|
Sale | 9,035 | Feb 17, 2026 | Feb. 19, 2026, 5:30 p.m. |
SRRK
|
Sale | 6,600 | Jan 16, 2026 | Jan. 21, 2026, 8:51 p.m. |
SRRK
|
Sale | 2,178 | Aug 18, 2025 | Aug. 19, 2025, 4:30 p.m. |
SRRK
|
Sale | 6,186 | Jun 16, 2025 | June 17, 2025, 4:30 p.m. |
SRRK
|
Sale | 5,296 | Feb 18, 2025 | Feb. 20, 2025, 7:30 p.m. |
SRRK
|
Sale | 6,434 | Jan 16, 2025 | Jan. 21, 2025, 5:35 p.m. |
SRRK
|
Sale | 1,451 | Aug 16, 2024 | Aug. 19, 2024, 5 p.m. |
SRRK
|
Sale | 4,305 | Jun 17, 2024 | June 18, 2024, 5:55 p.m. |
SRRK
|
Sale | 3,751 | Feb 16, 2024 | Feb. 20, 2024, 5:52 p.m. |
SRRK
|
Sale | 2,849 | Jan 16, 2024 | Jan. 18, 2024, 5:08 p.m. |
SRRK
|
Sale | 1,353 | Aug 16, 2023 | Aug. 18, 2023, 4:05 p.m. |
$SRRK Executives and Stock Owners with Insider Trades
-
Mo Qatanani, CHIEF SCIENTIFIC OFFICER
-
Edward H Myles, COO & CFO
-
Jing L. Marantz, CHIEF MEDICAL OFFICER
-
Caryn Parlavecchio, CHRO
-
Junlin Ho, GENERAL COUNSEL
-
Tracey Sacco, Chief Commercial Officer
-
Akshay Vaishnaw, President of R&D
-
Edward H Myles, Chief Financial Officer
-
Jay T. Backstrom, CHIEF EXECUTIVE OFFICER
-
Mo Qatanani, SVP AND HEAD OF RESEARCH
-
David Hallal, Chief Executive Officer
-
Keith Woods, Chief Operating Officer
-
Tracey Sacco, CHIEF COMMERCIAL OFFICER
-
Vikas Sinha, Chief Financial Officer
-
Erin Moore, Interim PFO and PAO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.